Aspen Valley Health has opened a new Rehabilitation and Sports Medicine clinic in downtown Aspen, offering access to physical ...
Clemson football has lost another key defender to the portal. Jones (6-2, 195) is a huge loss for Clemson and the third player with starting experience to leave via the portal, joining junior safety ...
San Diego State safety Dwayne McDougle is entering the transfer portal. This was reported by CBSSports’ Matt Zenitz earlier this week. McDougle was productive for Rob Aurich’s Aztec defense. He had ...
Georgia safety Jaden Harris has entered the transfer portal. The Georgia Bulldogs 2025 college football season has officially come to a close following the Dawgs‘ heartbreaking loss to the Ole Miss ...
Despite AI's potential, human hospital staff efforts are still key in significantly improving patient safety. Artificial intelligence applications may dominate health care discourse, but the low-tech ...
A locally owned physical therapy and sports medicine clinic in Gettysburg is leaning on long one-on-one sessions, quick appointments, and hometown roots to stand out in a crowded rehabilitation market ...
Justin Stebbing does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
The Maryland Department of Public Safety and Correctional Services ordered the emergency transfer Thursday of individuals being held at the Baltimore-based Maryland Reception, Diagnostics, and ...
Introduction Spinal manipulative therapy (SMT) is a common manual therapy intervention provided by healthcare providers for patients with low back pain (LBP). Responses to SMT are influenced by ...
Please provide your email address to receive an email when new articles are posted on . Abridged dual therapy followed by direct oral anticoagulant monotherapy after PCI may be safe vs. 1 year of dual ...
The regulator has received reports that a group of patients treated with Adzynma had neutralizing antibodies against the protein the therapy replaces. The FDA is investigating adverse events, ...